Dreicer R - Search Results

1

Escalated dosages of methotrexate, vinblastine, doxorubicin, and cisplatin plus recombinant human granulocyte colony-stimulating factor in advanced urothelial carcinoma: an Eastern Cooperative Oncology Group trial.

Loehrer PJ Sr, Elson P, Dreicer R, Hahn R, Nichols CR, Williams R, Einhorn LH. Loehrer PJ Sr, et al. Among authors: dreicer r. J Clin Oncol. 1994 Mar;12(3):483-8. doi: 10.1200/JCO.1994.12.3.483. J Clin Oncol. 1994. PMID: 7509853 Clinical Trial.

2

Controversies in urologic oncology.

Dreicer R, See W, Williams R. Dreicer R, et al. Iowa Med. 1991 Aug;81(8):343-5. Iowa Med. 1991. PMID: 1938300 No abstract available.

3

Perioperative methotrexate, vinblastine, doxorubicin and cisplatin (M-VAC) for poor risk transitional cell carcinoma of the bladder: an Eastern Cooperative Oncology Group pilot study.

Dreicer R, Messing EM, Loehrer PJ, Trump DL. Dreicer R, et al. J Urol. 1990 Nov;144(5):1123-6; discussion 1126-7. doi: 10.1016/s0022-5347(17)39673-8. J Urol. 1990. PMID: 2231884 Clinical Trial.

4

Phase II trial of 5-fluorouracil and alpha-2b interferon in patients with hormone-refractory metastatic prostate cancer.

Dreicer R, Forest PK, Williams RD. Dreicer R, et al. Urology. 1994 Sep;44(3):377-80. doi: 10.1016/s0090-4295(94)80096-0. Urology. 1994. PMID: 7521094 Clinical Trial.

5

Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group.

Roth BJ, Dreicer R, Einhorn LH, Neuberg D, Johnson DH, Smith JL, Hudes GR, Schultz SM, Loehrer PJ. Roth BJ, et al. Among authors: dreicer r. J Clin Oncol. 1994 Nov;12(11):2264-70. doi: 10.1200/JCO.1994.12.11.2264. J Clin Oncol. 1994. PMID: 7525883 Clinical Trial.

6

Phase II trial of vinblastine, ifosfamide, and gallium combination chemotherapy in metastatic urothelial carcinoma.

Einhorn LH, Roth BJ, Ansari R, Dreicer R, Gonin R, Loehrer PJ. Einhorn LH, et al. Among authors: dreicer r. J Clin Oncol. 1994 Nov;12(11):2271-6. doi: 10.1200/JCO.1994.12.11.2271. J Clin Oncol. 1994. PMID: 7525884 Clinical Trial.

7

DNA ploidy and P-glycoprotein expression as predictive factors of response to neoadjuvant chemotherapy for invasive bladder cancer.

Sandlow J, Cohen MB, Robinson RA, Dreicer R, Williams RD. Sandlow J, et al. Among authors: dreicer r. Urology. 1994 Jun;43(6):787-91. doi: 10.1016/0090-4295(94)90136-8. Urology. 1994. PMID: 7910989

8

Neoadjuvant cisplatin, methotrexate and vinblastine for muscle-invasive bladder cancer: long-term followup.

Dreicer R, Kollmorgen TA, Smith RF, Williams RD. Dreicer R, et al. J Urol. 1993 Sep;150(3):849-52. doi: 10.1016/s0022-5347(17)35630-6. J Urol. 1993. PMID: 8345598

9

Management of prostate and bladder cancer in the elderly.

Dreicer R, Cooper CS, Williams RD. Dreicer R, et al. Urol Clin North Am. 1996 Feb;23(1):87-97. doi: 10.1016/s0094-0143(05)70295-0. Urol Clin North Am. 1996. PMID: 8677539 Review.

10

Paclitaxel in advanced urothelial carcinoma: its role in patients with renal insufficiency and as salvage therapy.

Dreicer R, Gustin DM, See WA, Williams RD. Dreicer R, et al. J Urol. 1996 Nov;156(5):1606-8. doi: 10.1016/s0022-5347(01)65459-4. J Urol. 1996. PMID: 8863548 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

263 results

Search Page

Filters